Critical Path Institute's Predictive Safety Testing Consortium (PSTC) Announces First-Ever Biomarker Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) TUCSON, ...
TUCSON, Ariz., May 8, 2025 /PRNewswire/ -- The year 2025 marks a historic milestone for Critical Path Institute ® (C-Path), as the organization celebrates 20 years of transforming the landscape of ...
The European Medicines Agency sent a letter of support for Critical Path Institute’s efforts to establish a model-based clinical trial simulation platform that could help find new treatments for ...
TUCSON and FLAGSTAFF, Ariz. -- May 1, 2017 -- The Critical Path to TB Drug Regimens (CPTR), an initiative of the Critical Path Institute (C-Path), has received a $1.1 million grant from the Bill & ...
Tucson, AZ -- January 22, 2018 -- Critical Path Institute (C-Path) announced today that the European Medicines Agency (EMA) has issued a Letter of Support for measurement of glutamate dehydrogenase ...
TUCSON, Ariz.--(BUSINESS WIRE)-- Critical Path Institute (C-Path) is proud to announce that the Regulatory Science Consortium, an arm of the Critical Path to TB Drug Regimens (CPTR), has added 10 new ...
Marc Cantillon, MD, presents the critical role of public/private partnerships in creating innovative tools to advance the development of new Alzheimer’s disease therapies Despite alarming statistics ...
TUCSON, Ariz.--(BUSINESS WIRE)-- A special May 10, 2010 issue of Nature Biotechnology (NBT) includes ten scientific publications from Critical Path Institute’s (C-Path) Predictive Safety Testing ...
TUCSON, Ariz.--(BUSINESS WIRE)--Critical Path Institute (C-Path) announced today that Dr. Carolyn Compton has joined the organization as its new president and chief executive officer. Dr. Compton ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
The Tucson-based Critical Path Institute has no laboratories, no drug chemists, no patent lawyers. Yet the nonprofit is arguably one of the most important emerging drug-research organizations in the ...
CPATH Cerebral Palsy Awareness Transition Hope was hit with a trademark infringement lawsuit on Nov. 4 in Arizona District Court over its alleged unauthorized use of the 'CPATH' mark. The action, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results